Lithium for Alzheimer’s Disease
Research shows lithium’s crucial role in maintaining healthy brain function and its potential to protect against brain aging and the onset of Alzheimer’s Disease.
Lithium Deficiency and the Onset of Alzheimer’s Disease
Meet the Research Team
- Pilot Study (PDF)
- Funding Appeal
- Meet the Researchers
- News and Announcements
- Mental Health Biomarkers
- Suicide Prevention
- Lithium for Alzheimer’s
- Lithium for Addiction
Facebook
Instagram
Youtube
Twitter
Could Lithium Be the Key to Understanding and Treating Alzheimer’s Disease?
Recent research highlighting Lithium deficiency and the onset of Alzheimer’s Disease shows lithium’s crucial role in maintaining healthy brain function and its potential to protect against brain aging and the onset of Alzheimer’s Disease. Scientists found that lithium levels in the brain diminish as they bind with harmful amyloid plaques, illustrating a new pathway for the progression of Alzheimer’s. The team discovered that administering low-dose lithium-based compounds sidesteps this binding issue, with data showing promise in reversing symptoms of Alzheimer’s and brain aging in mice, all without toxic side effects.
Understanding Alzheimer’s Disease:
Alzheimer’s Disease is a complex condition that impacts between 50 and 400 million people globally, characterized by various brain anomalies, including accumulations of the protein amyloid beta, neurofibrillary tangles made of tau protein, and a decline in a protective protein known as REST. Environmental elements also play a significant role, with long-term exposure to air and noise pollution, as well as heavy metals such as aluminum and lead, pesticide residues, and poor water quality, being key contributing factors. However, the presence of these known risk factors does not guarantee that individuals will present symptoms of early-onset Alzheimer’s Disease nor show signs of cognitive impairment at all. For people who do, current treatments focusing on amyloid beta often fail to reverse memory loss effectively and only slightly slow down the deterioration of cognitive function. While both genetic and environmental influences impact Alzheimer’s risk, the reasons behind why some people with identical risk factors develop the Disease while others do not remain a mystery.
The Role of Lithium:
According to the study’s authors, lithium may represent an essential piece of the puzzle in understanding the genesis of Alzheimer’s Disease. The latest findings suggest that lithium is naturally present in the brain, playing a vital role in preventing neurodegeneration and supporting the proper function of all primary brain cell types. Based on a decade of experiments on mice and analyses of human brain tissue and blood from individuals at various stages of cognitive health, researchers discovered that a decline in lithium levels is among the earliest biomarkers associated with Alzheimer’s in humans. In mouse models, a similar depletion of lithium showed accelerated brain deterioration and cognitive decline. They identified this loss as a result of lithium binding to amyloid plaques and difficulties in cellular uptake. In a series of groundbreaking experiments, the research team found that micro-doses of lithium, which do not bind to the amyloid plaques, successfully restored memory in mice and improved symptoms related to early-stage dementia and Alzheimer’s Disease. These promising findings open new avenues for treatment interventions in the ongoing battle against Alzheimer’s.
LIP Study News & Announcements
Read the Lithium Inflammation Psychiatry (LIP) Study (PDF)
A Double-Blind, Placebo-Controlled, Crossover Study.
Health Effects of Low-Dose Lithium: A Systematic Review
See the latest Articles and Posts about the LIP Study.
Mental Health & Low-Dose Lithium
Low-Dose Lithium Research Team from the Karolinska Institute
Personality Disorder Research Team from the Karolinska Institute
News Archives